Skip to content

Innoviva, Inc. INVA Enterprise value

Enterprise value at other companies

Pfizer logo
PfizerPFE
$222.4B+9.2%
Merck & Co. logo
Merck & Co.MRK
$341.11B+34.2%
AbbVie logo
AbbVieABBV
$460.96B+24.7%
Insmed logo
InsmedINSM
$35.25B+142%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$12.92B+175%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$958.05M+65.4%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
P/E3.5×
P/S4.1×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Calculated from Innoviva, Inc.’s reported figures.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s enterprise value?
Innoviva, Inc. (INVA) reported enterprise value of $1.39B in Q1 2026.
How has Innoviva, Inc.'s enterprise value changed year-over-year?
Innoviva, Inc.'s enterprise value increased by 9.7% year-over-year, from $1.27B to $1.39B.
What is the long-term trend for Innoviva, Inc.'s enterprise value?
Over 5 years (2020 to 2025), Innoviva, Inc.'s enterprise value has grown at a 3.9% compound annual growth rate (CAGR), from $1B to $1.21B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.